Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Octreotide × Breast × Clear all

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3 NET 1 Endocrine 1 Breast 1

Conditions

Lymphocele 1 Breast Neoplasms 1

Interventions

Exercise 111 Surveys and Questionnaires 53 Magnetic Resonance Spectroscopy 50 Early Intervention, Educational 50 Standard of Care 48 Educational Status 47 Methods 46 Acupuncture Therapy 44 Blood Specimen Collection 39 Radiotherapy 38 Mammography 38 Control Groups 33 Counseling 30 Therapeutics 28 Practice Guidelines as Topic 27 Psychiatric Rehabilitation 26 Biopsy 26 Sentinel Lymph Node Biopsy 25 Cyclophosphamide 25 Yoga 22 Resistance Training 20 Interviews as Topic 20 Palliative Care 18 Neoadjuvant Therapy 18 Mastectomy, Segmental 18 High-Energy Shock Waves 17 Cognitive Behavioral Therapy 17 Trastuzumab 15 Surgical Procedures, Operative 15 Radiosurgery 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated

Breast Neoplasms, Lymphocele

Data powered by HemOnc (CC BY 4.0) Colophon ⚡